NO20004663D0 - Anti-tumor-midler - Google Patents

Anti-tumor-midler

Info

Publication number
NO20004663D0
NO20004663D0 NO20004663A NO20004663A NO20004663D0 NO 20004663 D0 NO20004663 D0 NO 20004663D0 NO 20004663 A NO20004663 A NO 20004663A NO 20004663 A NO20004663 A NO 20004663A NO 20004663 D0 NO20004663 D0 NO 20004663D0
Authority
NO
Norway
Prior art keywords
alkyl
hydrogen
tumor agents
benzensulphonyloxy
alkynylimino
Prior art date
Application number
NO20004663A
Other languages
English (en)
Other versions
NO20004663L (no
Inventor
Francis Thomas Boyle
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20004663D0 publication Critical patent/NO20004663D0/no
Publication of NO20004663L publication Critical patent/NO20004663L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/72—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms
    • C07C235/76—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
    • C07C235/78—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton the carbon skeleton containing rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO20004663A 1998-03-20 2000-09-19 Anti-tumor-midler NO20004663L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9805868.8A GB9805868D0 (en) 1998-03-20 1998-03-20 Anti-tumour agents
PCT/GB1999/000786 WO1999048860A1 (en) 1998-03-20 1999-03-16 Anti-tumour agents

Publications (2)

Publication Number Publication Date
NO20004663D0 true NO20004663D0 (no) 2000-09-19
NO20004663L NO20004663L (no) 2000-11-13

Family

ID=10828860

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20004663A NO20004663L (no) 1998-03-20 2000-09-19 Anti-tumor-midler

Country Status (19)

Country Link
US (1) US6472435B1 (no)
EP (1) EP1064257B1 (no)
JP (1) JP2002507592A (no)
KR (1) KR20010042056A (no)
CN (1) CN1178900C (no)
AT (1) ATE231836T1 (no)
AU (1) AU746715B2 (no)
BR (1) BR9908934A (no)
CA (1) CA2319335A1 (no)
DE (1) DE69905143T2 (no)
DK (1) DK1064257T3 (no)
ES (1) ES2192036T3 (no)
GB (1) GB9805868D0 (no)
IL (1) IL138590A (no)
NO (1) NO20004663L (no)
NZ (1) NZ506011A (no)
PT (1) PT1064257E (no)
WO (1) WO1999048860A1 (no)
ZA (1) ZA200004386B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9805866D0 (en) 1998-03-20 1998-05-13 Zeneca Ltd Anti-tumour agents
US6413533B1 (en) * 1998-05-07 2002-07-02 The University Of Tennessee Research Corporation Method for chemoprevention of prostate cancer
US20060099712A1 (en) * 2004-11-08 2006-05-11 Eastman Kodak Company Correlation of anti-cancer activity of dyes with redox potentials
WO2006099507A2 (en) * 2005-03-11 2006-09-21 Medical Instill Technologies, Inc. Sterile de-molding apparatus and method
US7872050B2 (en) 2005-03-14 2011-01-18 Yaupon Therapeutics Inc. Stabilized compositions of volatile alkylating agents and methods of using thereof
US8501818B2 (en) * 2005-03-14 2013-08-06 Ceptaris Therapeutics, Inc. Stabilized compositions of alkylating agents and methods of using same
US20110039943A1 (en) * 2005-03-14 2011-02-17 Robert Alonso Methods for treating skin disorders with topical nitrogen mustard compositions
US20110104250A1 (en) * 2007-09-07 2011-05-05 Mccarley Robin L Redox-gated Liposomes
LT3494960T (lt) 2008-03-27 2021-02-25 Helsinn Healthcare Sa Stabilizuotos alkilinimo agentų kompozicijos ir jų naudojimo būdai
KR101006166B1 (ko) * 2008-12-10 2011-01-07 건국대학교 산학협력단 지하철 역 선로에 설치되는 자기성 분진 수거 장치 및 그 방법
MX357284B (es) * 2011-05-26 2018-07-04 Univ Indiana Res & Tech Corp Compuestos de quinona para tratar enfermedades mediadas por ape1.
US20140128398A1 (en) 2011-06-03 2014-05-08 Indiana University Research And Technology Corporation Compounds, compositions and methods for treating oxidative dna damage disorders
US10730903B2 (en) 2016-09-19 2020-08-04 Memorial Sloan-Kettering Cancer Center Adenosine analogs as methyltransferase inhibitors for treating cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0002677B1 (en) * 1977-12-02 1982-10-13 Takeda Chemical Industries, Ltd. Glucosamine-peptide derivatives and their pharmaceutical compositions
JPS58177934A (ja) 1982-04-13 1983-10-18 Takeda Chem Ind Ltd ベンゾキノン誘導体
NZ240785A (en) 1991-11-28 1995-08-28 Cancer Res Campaign Tech Substituted nitro aniline derivatives and medicaments
GB9805866D0 (en) 1998-03-20 1998-05-13 Zeneca Ltd Anti-tumour agents

Also Published As

Publication number Publication date
IL138590A0 (en) 2001-10-31
BR9908934A (pt) 2005-10-25
ATE231836T1 (de) 2003-02-15
GB9805868D0 (en) 1998-05-13
NZ506011A (en) 2002-10-25
NO20004663L (no) 2000-11-13
EP1064257A1 (en) 2001-01-03
CN1178900C (zh) 2004-12-08
CN1293656A (zh) 2001-05-02
EP1064257B1 (en) 2003-01-29
DK1064257T3 (da) 2003-05-26
AU746715B2 (en) 2002-05-02
DE69905143D1 (de) 2003-03-06
ZA200004386B (en) 2002-01-30
JP2002507592A (ja) 2002-03-12
CA2319335A1 (en) 1999-09-30
WO1999048860A1 (en) 1999-09-30
KR20010042056A (ko) 2001-05-25
AU2846799A (en) 1999-10-18
US6472435B1 (en) 2002-10-29
ES2192036T3 (es) 2003-09-16
PT1064257E (pt) 2003-06-30
DE69905143T2 (de) 2003-11-20
IL138590A (en) 2004-08-31

Similar Documents

Publication Publication Date Title
DE69905143D1 (de) Anti-tumor-mittel
DK1023308T3 (da) Inhibitorer af nukleosidmetabolisme
NO20004778L (no) Amidderivater og nociceptin antagonister
PL368409A1 (en) Derivatives of triazolyl-imidazopyridine and of the triazolylpurines useful as ligands of the adenosine a2a? receptor and their use as medicaments
MXPA05009359A (es) Tetrahidroisoquinolinas 2,5- y 2,6 substituidas para uso como moduladores 5-ht6.
TR200100075T2 (tr) 2-Kuinolon ihtiva eden farmasötik bileşimler
DK0791006T3 (da) Polyanioniske benzylglylcosider som inhibitorer af proliferation af glatte muskelceller
NZ334954A (en) Substituted heterocycles as anti-tumor agents
MY139612A (en) Benzoxazine derivatives as 5-th6 modulators and uses thereof
ATE248167T1 (de) Tetrazole derivate
TR200101979T2 (tr) Antidepresyon tedavisi için 5HT1 antagonistleri.
IL114968A (en) 1,4-dihydropyridine compounds and pharmaceutical compositions containing them
ES455741A1 (es) Un procedimiento para la preparacion de nuevos derivados de 1,3-bencenodimetanol.
PL335012A1 (en) Novel derivatives of indan-1-ole, method of obtaining and composition containing them
BR9604907A (pt) Derivados de nucleosideos hamocarbociclico de pirimidinodiona substituida aniviral e métodos de preparo dos mesmos e composiçoes contendo tais derivados como principios ativos
ES2190199T3 (es) Agentes anti-tumorales.
PT944618E (pt) Novos compostos de n-benzenossulfonilo-1-prolina processo de preparacao e utilizacao em terapia
WO2004110379A3 (en) A1 adenosine receptor antagonists
KR970706280A (ko) 5-HT1A 길항제로서의 비사이클릭 카복스아미드(Bicyclic carboxamides as 5-HT1 antagonists)
KR960007560A (ko) 신규한 아민 유도체, 그의 제조방법 및 항부정맥제로서의 용도
TW200509927A (en) Chronic obstructive pulmonary disease therapeutic agent and method of treating chronic obstructive pulmonary disease using the same

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application